MERIT MEDICAL SYSTEMS INC

COO’s 21,449‑share sale at $85.00 shows short‑term profit‑taking, not a bearish shift, as Merit Medical’s fundamentals and growth stay strong.

Merit Medical’s latest insider sale is a routine move, while its robust stent portfolio, low adverse event rates, and expanding regulatory approvals signal steady growth in interventional cardiology.

Merit Medical’s insider buying signals optimism amid a volatile market. Discover why Thomas J. Gunderson’s disciplined purchases suggest potential upside for long‑term investors.

Goldberg’s steady buy of 2,000 Merit Medical shares shows insider confidence, hinting at value amid a shaky market and strong high‑margin device pipeline.